NCS Multistage Q2 Revenue Beats, But EBITDA Misses Ahead of Weatherford Merger
NCSM sits 54% above its 52-week low of $29.48 on light trading volume (0.2× avg).
Summary
NCS Multistage reported Q2 revenue of $38.4M, edging past the $37.87M consensus, but adjusted EBITDA of $1.9M fell short of the $2.76M estimate. The company swung to a net loss from a profit a year ago. Revenue growth was driven by Repeat Precision and U.S. tracer diagnostics, while Canadian fracturing systems activity weakened due to customer project delays. The pending acquisition by Weatherford, announced in June, remains on track to close in H2 2026. With the stock trading near $45, well below the $69 analyst target, the merger terms are the primary valuation anchor, but the operational miss may raise questions about near-term standalone performance. NCS Multistage filed an 8-K regarding its operations and financial condition.
At the time of this announcement, NCSM was trading at $45.42 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $119.2M. The 52-week trading range was $29.48 to $87.36. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.